Altered miR-93-5p/miR-18a expression in serum for diagnosing non-small cell lung cancer
AJTR Copyright © 2021..
OBJECTIVE: This research aimed at probing into miR-93-5p and miR-18a's diagnostic and prognostic values in non-small cell lung cancer (NSCLC) patients.
METHODS: A total of 107 patients diagnosed with NSCLC in the Department of Oncology and Thoracic Surgery of our hospital from January 2015 to June 2016 were regarded as the research group (RG), and 42 healthy people were considered as the control group (CG). Serum samples were collected and miR-93-5p, miR-18a expression was detected via qPCR. The relationship between miR-93-5p, miR-18a and clinicopathological characteristics of NSCLC patients was assessed, and the diagnostic value of the two miRNAs was analyzed by ROC curve.
RESULTS: miR-93-5p and miR-18a were up-regulated in NSCLC. The higher the degree of tumor differentiation, the higher the TNM stage and the expression of the two miRNAs were. The high expression was tied to tumor differentiation degree, TNM stage, lymph node metastasis and lymph-vascular space invasion (LVSI). The survival rate of miR-93-5p and miR-18a high expression patients was worse than that of those with low expression. The AUC value of both of the mRNAs in NSCLC diagnosis was high (0.8905).
CONCLUSION: The expression of miR-93-5p and miR-18a is associated with NSCLC severity and prognosis, and both can be used as potential markers for diagnosis.
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
---|---|
Enthalten in: |
American journal of translational research - 13(2021), 5 vom: 07., Seite 5073-5079 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Shao, Lili [VerfasserIn] |
---|
Themen: |
Diagnostic value |
---|
Anmerkungen: |
Date Revised 22.06.2021 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM326975470 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM326975470 | ||
003 | DE-627 | ||
005 | 20231225195743.0 | ||
007 | tu | ||
008 | 231225s2021 xx ||||| 00| ||eng c | ||
028 | 5 | 2 | |a pubmed24n1089.xml |
035 | |a (DE-627)NLM326975470 | ||
035 | |a (NLM)34150094 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Shao, Lili |e verfasserin |4 aut | |
245 | 1 | 0 | |a Altered miR-93-5p/miR-18a expression in serum for diagnosing non-small cell lung cancer |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a Date Revised 22.06.2021 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a AJTR Copyright © 2021. | ||
520 | |a OBJECTIVE: This research aimed at probing into miR-93-5p and miR-18a's diagnostic and prognostic values in non-small cell lung cancer (NSCLC) patients | ||
520 | |a METHODS: A total of 107 patients diagnosed with NSCLC in the Department of Oncology and Thoracic Surgery of our hospital from January 2015 to June 2016 were regarded as the research group (RG), and 42 healthy people were considered as the control group (CG). Serum samples were collected and miR-93-5p, miR-18a expression was detected via qPCR. The relationship between miR-93-5p, miR-18a and clinicopathological characteristics of NSCLC patients was assessed, and the diagnostic value of the two miRNAs was analyzed by ROC curve | ||
520 | |a RESULTS: miR-93-5p and miR-18a were up-regulated in NSCLC. The higher the degree of tumor differentiation, the higher the TNM stage and the expression of the two miRNAs were. The high expression was tied to tumor differentiation degree, TNM stage, lymph node metastasis and lymph-vascular space invasion (LVSI). The survival rate of miR-93-5p and miR-18a high expression patients was worse than that of those with low expression. The AUC value of both of the mRNAs in NSCLC diagnosis was high (0.8905) | ||
520 | |a CONCLUSION: The expression of miR-93-5p and miR-18a is associated with NSCLC severity and prognosis, and both can be used as potential markers for diagnosis | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Non-small cell lung cancer | |
650 | 4 | |a diagnostic value | |
650 | 4 | |a miR-18a | |
650 | 4 | |a miR-93-5p | |
650 | 4 | |a prognosis analysis | |
700 | 1 | |a Lu, Xiaomin |e verfasserin |4 aut | |
700 | 1 | |a Zhou, Yan |e verfasserin |4 aut | |
700 | 1 | |a Wang, Yan |e verfasserin |4 aut | |
700 | 1 | |a Wang, Xiaoli |e verfasserin |4 aut | |
700 | 1 | |a Zhuang, Zhixiang |e verfasserin |4 aut | |
700 | 1 | |a Gong, Jun |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t American journal of translational research |d 2009 |g 13(2021), 5 vom: 07., Seite 5073-5079 |w (DE-627)NLM193229463 |x 1943-8141 |7 nnns |
773 | 1 | 8 | |g volume:13 |g year:2021 |g number:5 |g day:07 |g pages:5073-5079 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 13 |j 2021 |e 5 |b 07 |h 5073-5079 |